Comparison of Dapagliflozin, Lobeglitazone, and Its Combination in Efficacy and Safety

Condition:   Diabetes Type 2 Interventions:   Drug: Dapagliflozin 10mg Tab;   Drug: Lobeglitazone 0.5 mg;   Drug: Dapagliflozin + Lobeglitazone Sponsor:   Seoul National University Bundang Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials